Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout.

@article{Vieira2015OralTW,
  title={Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout.},
  author={Ang{\'e}lica Thomas Vieira and Izabela Baptista Galv{\~a}o and Fl{\'a}vio Almeida Amaral and Mauro Martins Teixeira and J R Nicoli and F S Martins},
  journal={Beneficial microbes},
  year={2015},
  volume={6 6},
  pages={
          799-806
        }
}
Gout is an acute inflammatory disease characterised by the presence of uric acid crystals in the joint. This event promotes neutrophil infiltration and activation that leads to tissue damage. We investigated here whether the oral administration of the probiotic strain Bifidobacterium longum 5(1A) (BL) could ameliorate monosodium urate crystal (MSU)-induced inflammation in a murine model of gout. Mice received oral administration of BL or saline daily for 7 days and then were injected with MSU… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 47 REFERENCES

Epidemiology of gout.

  • Rheumatic diseases clinics of North America
  • 2014
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…